Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis

1. Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC et al. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 2006; 124 (11): 1532–1542.

   Article  CAS  Google Scholar 

2. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419–1431.

   Article  CAS  Google Scholar 

3. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ . Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364 (20): 1897–1908.

   Article  CAS  Google Scholar 

4. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C et al. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 2013; 120 (1): 122–129.

   Article  Google Scholar 

5. Amsler M . L'Examen qualitatif de la fonction maculaire. Ophthalmologica 1947; 114: 248–261.

   Article  Google Scholar 

6. Goldstein M, Loewenstein A, Barak A, Pollack A, Bukelman A, Katz H et al. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 2005; 25 (3): 296–303.

   Article  Google Scholar 

7. Kaiser PK, Wang YZ, He YG, Weisberger A, Wolf S, Smith CH . Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study. Retina 2013; 33 (9): 1863–1870.

   Article  Google Scholar 

8. Wang YZ, Wilson E, Locke KG, Edwards AO . Shape discrimination in age-related macular degeneration. Invest Ophthalmol Vis Sci 2002; 43 (6): 2055–2062.

   PubMed  Google Scholar 

9. Lim JH, Wickremasinghe SS, Xie J, Chauhan DS, Baird PN, Robman LD et al. Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol 2012; 153 (4): 678–686 686 e671-672.

   Article  CAS  Google Scholar 

10. Moher D, Liberati A, Tetzlaff J, Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.

    Article  Google Scholar 

11. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282 (11): 1061–1066.

    Article  CAS  Google Scholar 

12. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155 (8): 529–536.

    Article  Google Scholar 

13. Harbord RM, Whiting P, Sterne JA, Egger M, Deeks JJ, Shang A et al. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol 2008; 61 (11): 1095–1103.

    Article  Google Scholar 

14. Zwinderman AH, Bossuyt PM . We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 2008; 27 (5): 687–697.

    Article  Google Scholar 

15. Chou R, Dana T, Bougatsos C . Screening older adults for impaired visual acuity: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 1511: 44–58 W11-20.

    Article  Google Scholar 

16. Crossland M, Rubin G . The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol 2007; 91 (3): 391–393.

    Article  Google Scholar 

17. Bachmann LM, Juni P, Reichenbach S, Ziswiler HR, Kessels AG, Vogelin E . Consequences of different diagnostic "gold standards" in test accuracy research: Carpal Tunnel Syndrome as an example. Int J Epidemiol 2005; 34 (4): 953–955.

    Article  Google Scholar 

18. Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the eye (HOME) study. Ophthalmology 2014; 121 (2): 535–544.

    Article  Google Scholar 

19. Chhetri AP, Wen F, Wang Y, Zhang K . Shape discrimination test on handheld devices for patient self-test. Proceedings of the 1st ACM International Health Informatics Symposium 2010 ACM New York, NY, USA 2010: 502–506.

    Google Scholar 

20. Wang YZ, He YG, Mitzel G, Zhang S, Bartlett M . Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy. Invest Ophthalmol Vis Sci 2013; 54 (8): 5497–5505.

    Article  Google Scholar 

21. Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL . Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 1986; 104 (4): 513–514.

    Article  CAS  Google Scholar 

22. Nowomiejska K, Oleszczuk A, Brzozowska A, Grzybowski A, Ksiazek K, Maciejewski R et al. M-charts as a tool for quantifying metamorphopsia in age-related macular degeneration treated with the bevacizumab injections. BMC Ophthalmol 2013; 13: 13.

    Article  Google Scholar 

23. Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ et al. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 2005; 112 (10): 1758–1765.

    Article  Google Scholar 

24. Isaac DL, Avila MP, Cialdini AP . Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration. Arq Bras Oftalmol 2007; 70 (5): 771–776.

    Article  Google Scholar 

25. Lai Y, Grattan J, Shi Y, Young G, Muldrew A, Chakravarthy U . Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter. Retina 2011; 31 (8): 1620–1626.

    Article  Google Scholar 

26. Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology 2003; 110 (5): 966–970.

    Article  Google Scholar 

27. Loewenstein A, Ferencz JR, Lang Y, Yeshurun I, Pollack A, Siegal R et al. Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device. Retina 2010; 30 (7): 1058–1064.

    Article  Google Scholar 

28. Mathew R, Sivaprasad S . Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration. Eye 2012; 26 (3): 389–393.

    Article  CAS  Google Scholar 

29. Robison CD, Jivrajka RV, Bababeygy SR, Fink W, Sadun AA, Sebag J . Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing. Br J Ophthalmol 2011; 95 (10): 1419–1423.

    Article  Google Scholar 

30. Arimura E, Matsumoto C, Nomoto H, Hashimoto S, Takada S, Okuyama S et al. Correlations between M-CHARTS and PHP findings and subjective perception of metamorphopsia in patients with macular diseases. Invest Ophthalmol Vis Sci 2011; 52 (1): 128–135.

    Article  Google Scholar 

31. Klatt C, Sendtner P, Ponomareva L, Hillenkamp J, Bunse A, Gabel VP et al. Diagnostics of metamorphopsia in retinal diseases of different origins. Ophthalmologe 2006; 103 (11): 945–952.

    Article  CAS  Google Scholar 

32. Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE . [Comparison of Preferential Hyperacuity Perimeter (PHP) test and Amsler grid test in the diagnosis of different stages of age-related macular degeneration]. Klin Monbl Augenheilkd 2006; 223 (9): 752–756.

    Article  CAS  Google Scholar 

Download references